GPC1 and esophageal squamous cell carcinoma: In this direction, two interesting preclinical studies were performed in PDAC and ESCC in-vitro and in-vivo models using an anti-GPC1 conjugated with monomethyl auristatin F and monomethyl auristatin E, respectively [98,108].